Pigment evaluation and melasma care · Chaska, Minnesota
Melasma Diagnosis and Treatment
Melasma causes patterned facial pigmentation that often improves with treatment but has a strong tendency to return. Good management starts by confirming the diagnosis, protecting against ultraviolet and visible light, choosing treatment that fits the skin and medical history, and planning for maintenance.
Scenic Dermatology evaluates brown and gray-brown facial patches in Chaska. You do not need to decide whether the change is melasma, post-inflammatory hyperpigmentation, sun spots, or another pigment disorder before scheduling.
Melasma at a glance
Control is a better goal than a one-time cure
- Chronic: Melasma commonly improves and then recurs.
- Not contagious: It cannot spread from one person to another.
- Light responsive: Ultraviolet and visible light both matter.
- Maintenance dependent: Keeping improvement is part of treatment.
A chronic pigmentary disorder
What Is Melasma?
Melasma is an acquired disorder in which pigment-producing activity becomes persistently over-responsive. It most often creates larger, irregular patches on both sides of the face, including the cheeks, forehead, upper lip, nose, chin, and other central facial areas. The color may look tan, brown, gray-brown, or deeper than nearby skin.
Older terms include chloasma and the mask of pregnancy. Pregnancy is one important association, but melasma is not limited to pregnancy and does not mean that someone has a hormone imbalance.
Patterned
Melasma commonly forms broad patches in a roughly symmetric facial pattern rather than one isolated spot.
Multifactorial
Individual susceptibility, ultraviolet radiation, visible light, hormones, pregnancy, and other influences can interact. One universal root cause is unlikely.
Relapse prone
Visible pigment may lighten while the underlying tendency remains. Recurrence does not automatically mean treatment failed.
Melasma can occur across skin tones and genders, but it is especially common and clinically important in people whose skin produces more pigment after light or inflammation. Treatment-related irritation may create additional post-inflammatory hyperpigmentation, so a stronger or faster intervention is not always safer or more effective.
Diagnosis before dark-spot treatment
Is Every Brown Facial Patch Melasma?
No. A dermatologist usually diagnoses melasma from the history, distribution, color, and surface appearance. Dermoscopy, a Wood’s lamp examination, medication and product review, or another focused test may help when the pattern is unclear. Biopsy is not routine, but it can be considered when another diagnosis needs to be excluded.
| Possibility | Typical clue | Why the distinction matters |
|---|---|---|
| Melasma | Larger, often symmetric facial patches without a preceding rash or injury. | Light exposure, hormone context, pigment-suppressing treatment, and maintenance all shape the plan. |
| Post-inflammatory hyperpigmentation | Color follows acne, eczema, a burn, irritation, a procedure, or another inflammatory event. | Controlling the original inflammation and avoiding new injury may be as important as treating pigment. |
| Solar lentigines | More discrete, focal “sun spots” associated with cumulative ultraviolet exposure. | Spot-directed treatment can make sense for a lentigo but may be the wrong mental model for patterned melasma. |
| Another pigment disorder | Medication-related color, pigmented contact dermatitis, lichen planus pigmentosus, ochronosis, or another pattern may resemble melasma. | A treatment chosen for melasma may be ineffective or counterproductive when the diagnosis is different. |
More than one process can be present. Someone can have melasma and post-inflammatory pigment from acne, eczema, irritation, or a procedure at the same time. That overlap is one reason an inflamed “brightening” routine can make the overall face look darker.
Two light exposures, one practical plan
Why Ultraviolet and Visible Light Both Matter
Broad-spectrum ultraviolet protection is essential for melasma. Visible light can also stimulate pigmentation, with an especially important effect in darker skin tones. This is why a sunscreen plan for melasma may add a tint rather than relying only on a clear or untinted UV-filter formula.
The UV foundation
Choose broad-spectrum SPF 30 or higher, apply enough to exposed skin, and combine it with shade, a wide-brimmed hat, and other protective behavior. An untinted sunscreen that works for you still provides important UV protection.
The visible-light layer
Tinted sunscreens commonly use iron oxides as pigments. Those pigments can add visible-light protection. The tint still needs broad-spectrum SPF, and it needs to match well enough that you can wear it consistently.
Scenic’s guide to bemotrizinol and sunscreen selection explains why a UV filter does not replace the visible-light protection of a usable iron-oxide tint.
A gentle routine protects the treatment plan
A melasma routine that constantly burns, stings, peels, or inflames the skin can work against its own goal. Avoid stacking multiple new acids, scrubs, retinoids, lightening products, home peels, or devices at once. A simpler cleanser, moisturizer, sunscreen, and intentionally chosen treatment make it easier to identify benefit and irritation.
A strategy, not a treatment catalog
How Melasma Treatment Is Built
Treatment usually has two phases: improve the pigmentation, then maintain the improvement by limiting the signals that keep pigment production active. The exact sequence depends on diagnosis, skin tone, sensitivity, pregnancy or nursing status, medications, medical history, prior treatment, and how much the condition matters to the patient.
- Build the foundationUse consistent ultraviolet and visible-light protection while reducing avoidable irritation.
- Suppress active pigmentSelect a topical regimen with enough evidence and intensity for the individual skin and treatment phase.
- Add only when usefulConsider a systemic medicine or procedural adjunct only when potential benefit justifies added risk and burden.
- Plan maintenanceShift to a sustainable strategy and reassess if pigment returns or the skin becomes irritated.
Topical treatments for melasma
Active treatment is not maintenance forever. A regimen used to gain control may not be the right long-term regimen. Follow-up should define when to reassess response, irritation, and the transition to maintenance.
A systemic option for selected patients
When Oral Tranexamic Acid May Enter the Discussion
Tranexamic acid is a systemic antifibrinolytic medication. In the United States, oral tranexamic-acid tablets are FDA-approved for cyclic heavy menstrual bleeding, not melasma. Melasma treatment is therefore off-label. Studies support benefit in selected patients, but the evidence varies in quality and treatment does not remove the possibility of recurrence.
Oral TXA should not be treated as a casual “melasma pill.” The decision requires a real medical history and individualized risk assessment. A clinician may need to consider prior or active blood clots, intrinsic clotting risk, combined hormonal contraception, cardiovascular and menstrual history, kidney function, pregnancy, other medicines, and additional factors. For females of reproductive potential, the current U.S. tablet label contraindicates combined hormonal contraception and active, prior, or intrinsic thromboembolic risk.
Balanced safety counseling matters. A 2025 review found no thromboembolic events in the randomized trials it assessed. That is reassuring but does not prove zero risk, especially for a rare event or a patient excluded from trials. Screening should match the individual history rather than a universal online laboratory checklist.
Adjuncts, not the foundation
Where Procedures May Fit
Current evidence and international expert consensus support chemical peels and microneedling as possible adjuncts for selected patients. The useful word is adjunct: a procedure does not replace accurate diagnosis, photoprotection, irritation control, or a maintenance plan. Technique, skin tone, active inflammation, prior reactions, and the substance placed on or through treated skin all affect risk.
Lasers and light devices require greater restraint. Selected approaches may help refractory melasma, but improvement can be temporary and treatment can provoke recurrence or post-inflammatory hyperpigmentation. This is especially important in more deeply pigmented skin. A device should not be presented as the automatic next step after a cream.
Improvement is only half the plan
Maintenance Is Part of Melasma Treatment
Maintenance is not an afterthought added after a “successful” course. It is the phase designed to make improvement more durable while reducing unnecessary exposure to treatments that are not meant for continuous use.
- Active treatmentUse a defined regimen to reduce visible pigment while monitoring irritation.
- ReassessReview improvement, side effects, adherence, new triggers, and whether the original diagnosis still fits.
- MaintainContinue UV and visible-light protection and use a gentler long-term topical strategy when appropriate.
- Adjust if pigment returnsA flare can lead to a planned treatment change rather than uncontrolled product stacking.
Response is gradual and varies. Deeper or mixed pigment may be harder to improve. The aim is to lighten unwanted patches, make them less noticeable, and gain better control without asking the skin to become perfectly uniform.
Medication choices change during pregnancy
Melasma During and After Pregnancy
Pregnancy-associated hormonal changes can contribute to melasma. Some pigmentation fades after delivery, while some persists. During pregnancy, consistent photoprotection and a gentle routine remain useful, but prescription choices change. Standard options including topical retinoids, hydroquinone-containing regimens, and systemic treatment require clinician review and may not be appropriate.
Do not stop birth control, hormone therapy, or another prescribed medicine because of a melasma page. If a hormonal medication may be contributing, discuss the context, benefits, alternatives, and risks with the clinician who prescribes it. Melasma does not justify broad hormone testing in most people.
When facial pigmentation should be evaluated
- The diagnosis is uncertain or the color is new, changing, one-sided, or behaving unexpectedly.
- Over-the-counter lightening products repeatedly burn, sting, or worsen discoloration.
- You are considering prescription hydroquinone, triple-combination therapy, oral tranexamic acid, or a procedure.
- Pregnancy, nursing, contraception, another medicine, or a health condition complicates the choices.
- Prior treatment did not help or a maintenance plan is missing.
Melasma is medically harmless for most people, but its appearance can still affect quality of life. Treatment is optional. A useful consultation should respect how much or how little the condition matters to you.
Physician-led pigment evaluation
The Best Starting Point Is the Right Diagnosis
William Miller, MD, MSc, MPH, FAAD, evaluates the pattern, skin tone, prior inflammation, product and medication history, pregnancy context, medical risks, and treatment goals before recommending a plan. That diagnostic restraint matters because pigment can worsen when the wrong condition is treated too aggressively.
Explore Scenic’s broader medical dermatology and cosmetic dermatology pathways if you are unsure which type of visit fits.
Common questions
Melasma FAQs
Is melasma the same as hyperpigmentation?
No. Hyperpigmentation is a broad description for skin that appears darker than nearby skin. Melasma is one specific pigmentary disorder with a characteristic facial pattern and chronic tendency. Post-inflammatory hyperpigmentation, lentigines, medication-related pigment, and other disorders are different causes of hyperpigmentation.
Why is tinted sunscreen recommended for melasma?
Broad-spectrum sunscreen protects against ultraviolet radiation. A tinted formula containing iron oxides can add protection against visible light, which can worsen melasma and is especially relevant in darker skin tones. The tint does not replace SPF; look for both broad-spectrum SPF 30 or higher and a usable tint.
Can melasma be cured permanently?
Melasma can often be lightened and controlled, but it has a strong tendency to recur. A realistic plan includes active treatment, consistent photoprotection, and maintenance rather than promising permanent removal.
Is hydroquinone safe, and can it cause ochronosis?
Hydroquinone is an important evidence-based treatment when used in an appropriate supervised regimen. Irritation can occur. Prolonged or inappropriate exposure can rarely cause exogenous ochronosis, a paradoxical blue-black or darker discoloration. Use a defined plan and follow-up rather than indefinite self-treatment.
What is triple-combination cream?
Tri-Luma is an FDA-approved fixed triple-combination cream containing fluocinolone acetonide, hydroquinone, and tretinoin. It is labeled for short-term treatment of moderate-to-severe facial melasma with sun-avoidance measures and is not indicated for maintenance. Dermatologists may also prescribe customized combinations through a compounding pharmacy when the fixed product is not the best fit; those prescriptions are individualized rather than FDA-approved as a finished commercial product.
Is oral tranexamic acid FDA-approved for melasma, and does it cause blood clots?
Oral TXA is not FDA-approved for melasma. Evidence supports benefit in selected patients, and a 2025 review found no thromboembolic events in the randomized trials it assessed. That does not establish zero risk. Because TXA affects fibrinolysis, the decision requires individualized screening for clot-related risk, combined hormonal contraception, medical history, pregnancy, and other relevant factors.
Can microneedling or lasers help melasma?
Microneedling and selected peels may serve as adjuncts in some treatment plans. Lasers and light devices are usually considered more selectively, especially for refractory disease, because pigment can recur or worsen. A procedure should not replace photoprotection, topical strategy, or maintenance, and availability must be confirmed.
Should I stop birth control because of melasma?
Do not stop contraception or another prescribed hormonal medicine because of this page. Hormonal medication can contribute to melasma in some people, but changing it requires a discussion with the prescribing clinician. The decision should consider why the medicine is used, alternatives, pregnancy prevention, and your overall health.
Related Scenic care
Continue With the Question That Fits
Bring the pigment question
You Do Not Need to Diagnose the Patch Before Scheduling
If you are unsure whether facial pigmentation is melasma, post-inflammatory hyperpigmentation, sun spots, or another condition, Scenic Dermatology can help clarify the diagnosis and discuss a practical next step.